1 completed, 1 not yet recruiting, 1 withdrawn. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Not yet recruiting 1, Withdrawn 1 |
Follow C. Difficile Infection: new trials by email Literature Review of C. Difficile Infection trials Research Report on C. Difficile Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clostridioides Difficile Controlled Human Infection Model encapsulated 10^4 CFU toxigenic. C. difficile spores, Vancomycin, Clindamycin - C. Difficile, C. Difficile Infection | Not applicable | Not yet recruiting | Leiden University Medical Center | 60 | 2025-03-01 | 2024-11-22 |
| Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection Fecal Microbiota Transplantation (FMT) - C. Difficile Infection, Cancer | Not applicable | Completed | Memorial Sloan Kettering Cancer Center | 10 | 2016-05-10 | 2025-04-08 |
| Prospective Study of Clostridium Difficile in Children Undergoing Colonoscopy metronidazole - C. Difficile Infection | Not applicable | Withdrawn | State University of New York at Buffalo | 2011-12-01 | 2019-07-25 |
Neoplasms (1)
Clindamycin (1) · Fecal Microbiota Transplantation (1) · Metronidazole (1) · Vancomycin (1)
Leiden University Medical Center (1) · Memorial Sloan Kettering Cancer Center (1) · State University of New York at Buffalo (1)
United States (2) · Netherlands (1)